Navigation Links
Ideal Implant CEO Briefs North American Investors On New Advancements In Breast Implant Technology
Date:1/23/2020

Ideal Implant CEO and President Robert S Hamas, MD, presented new developments in the cosmetic surgery industry at two recent North American investor forums specializing in medical advancements. New technology was presented to US and Canadian investors at the Canaccord Genuity Medical Technologies & Diagnostics Forum on November 21, 2019 in New York City, and the Aesthetic Technology Summit in Orange County, California on January 10, 2020. Dr. Hamas, a widely-published retired plastic surgeon and medical device inventor with nine US patents, was invited to provide investors with insight into shifting trends and technologies in breast implants.

“IDEAL IMPLANT is a disruptive technology with strong clinical data that shows clear advantages over the silicone gel implants that have dominated the industry since they were allowed back in the US market in 2006,” explained Dr. Hamas. The IDEAL IMPLANT® Structured Breast Implant contains a novel internal structure that gives it the natural feel and look of silicone gel implants, but with only saline inside for a woman’s peace of mind. A key differentiator is that with the IDEAL IMPLANT, a woman can look in the mirror and know her implants are intact, while with silicone gel implants, rupture can occur without her knowledge (silent rupture), and require an MRI or ultrasound scan for detection.”

Dr. Hamas presented the latest market surveys showing that women consumers are spearheading a shift in implant preferences, pushing their surgeons toward increased adoption of this new technology over silicone gel implants. The data demonstrates that educated, proactive women consumers expect technology advancements, strong clinical data, and a better implant choice than silicone gel, sentiments which drove the development of IDEAL IMPLANT. The structured implant’s eight-year clinical trial data also recently showed the new implant outperforms silicone gel implants, with significantly lower rates of complications such as rupture and capsular contracture, further driving demand.

“While the IDEAL IMPLANT was launched as a luxury consumer product with premium pricing, the strong safety profile and a quickly growing, vocal pool of happy patients are driving strong patient interest across the board,” explains Dr. Hamas. “We have invested significantly to meet the growing pace of demand, and the IDEAL IMPLANT brand is increasingly well recognized. The current landscape presents a timely opportunity for market entry at a critical tipping point in consumer preferences.”

About Ideal Implant
Ideal Implant Incorporated, founded in 2006, is privately held and based in Dallas, TX. The Company has developed the IDEAL IMPLANT, designed the manufacturing processes including proprietary robotic shell fabrication technology, conducted a large US clinical trial and received PMA approval from FDA and Health Canada in 2014. The marketing strategy has been focused on the women consumers, who make the ultimate decision on their choice of implant. Growth in consumer demand has been rapid since commercial launch in 2015, and the IDEAL IMPLANT brand has become well recognized in the plastic surgery market. Plans are underway for expansion of manufacturing capacity to meet the growing demand. For more information, visit idealimplant.com.

Read the full story at https://www.prweb.com/releases/ideal_implant_ceo_briefs_north_american_investors_on_new_advancements_in_breast_implant_technology/prweb16852125.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. Anomet Composite Clad Metal Wire is Ideal for use in Sensors, Switches, Connectors, Implantable Medical Devices, and Other Applications in Harsh Environments
2. Telehealth Provider MYidealDOCTOR Forms Partnership with Zest Health
3. GEA Niro Soavi announces the Ariete NS5180 homogenizer, an ideal solution for the processing of nanoparticles, nanodispersions, nanoemulsions and cell dispersions.
4. Customers Tout Medrio’s EDC Software as Ideal Solution for Phase 1 Studies
5. New 13 Liter Refrigerated Open Tank Ideal for Laboratory Applications Requiring Bath Temperatures at or Below Ambient
6. LinkTech Inc. Launches Ideal Replacement for a Luer Fitting
7. Dr. Dan Myers Replaces Missing Teeth in Sandy Springs, GA, Offers Over 20 Years of Trusted Dental Implants Experience
8. Drs. Richard Amato and Michael Kang Improve Bone Grafts, Dental Implants and Tooth Extractions in Danbury, CT with Modern Technology
9. A Tiny Neural Implant Even Your Brain Can Love, From Draper
10. Periodontist Michael Hoge, DMD; MS of Precision Periodontics and Implant Dentistry Now Offers LANAP Laser Treatment for Gum Disease
11. Band-LOK Announces Allowance for Two New U.S Patents for the Tether Clamp and Implantation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2020)... ... July 30, 2020 , ... ... the life sciences industry, today announced the release of its signature product ... Medical Science Liaisons (MSLs) and other field medical professionals. , Beacon ...
(Date:7/18/2020)... ... July 16, 2020 , ... Medial EarlySign , ... and prevention of high-burden diseases, and Centric Consulting, a business and technology consulting ... utilize existing data in order to identify and prioritize patients for care. , ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most research using ... suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. ... has been using the zebrafish model to investigate the causes of leukaemia and ...
(Date:7/1/2020)... N.C. (PRWEB) , ... June 29, 2020 , ... ... reported year to date growth of 40% in 2020, despite many obstacles created ... technology, MedShift aims to increase revenue for its partnered medical practices and medical ...
Breaking Biology Technology:
(Date:7/18/2020)... ... July 16, 2020 , ... A study ... the Invictus Medical Neoasis™ active noise control device to attenuate typical noises in ... Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators and other bedside ...
(Date:7/2/2020)... , ... July 01, 2020 , ... ... its phase 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory ... 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer ...
(Date:6/28/2020)... ... ... In an upcoming episode scheduled for the fall of 2020, Advancements with Ted ... local listings for more info. , Today, the majority of testing is performed at ... the country. Results are then available several days later. Now, in an effort to ...
Breaking Biology News(10 mins):